Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt

Table 2

Effect of sociodemographic, transportation, and occupational exposure history on SARS-CoV-2 total and IgG antibodies results.

Characteristics	Total N (%) (199)	Total Ab (199)		IgG Ab (51)
		Negative (148)	Positive (51)	Negative (12)	Positive (39)
Gender
Male	74 (62.8%)	54 (73%)	20 (27%)	3 (29.0%)	17 (71.0%)
Female	125 (37.2%)	94 (75.2%)	31 (24.8%)	9 (15.0%)	22 (85.0%)
Age groups
22–32 Ys	84 (42.2%)	60 (71.4%)	24 (28.6%)	7 (41.2%)	10 (58.8%)
33–43 Ys	68 (34.1%)	53 (77.9%)	15 (22.1%)	3 (14.3%)	18 (85.7%)
44–59 Ys	47 (23.7%)	35 (74.5%)	12 (25.5%)	2 (15.4%)	11 (84.6%)
Residence
Urban	128 (64.3%)	90 (70.3%)	38 (29.7%)	10 (26.3%)	28 (73.7%)
Rural	71 (35.7%)	58 (81.7%)	13 (18.1%)	2 (15.4%)	11 (84.6%)
Job area
Doctors	28 (14.1%)	22 (78.6%)	6 (21.4%)	1 (16.7%)	5 (83.3%)
PCR lab	13 (6.5%)	12 (92.3%)	1 (7.7%)	0 (0.0%)	1 (100%)
Microbiology lab	18 (9%)	13 (72.2%)	5 (27.8%)	3 (60.0%)	2 (40.0%)
Parasitology lab	10 (5%)	9 (90%)	1 (10%)	0 (0.0%)	1 (100%)
Phlebotomy	9 (4.5%)	5 (55.5%)	4 (44.5%)	0 (0.0%)	4 (100%)
Outpatient clinic	19 (9.5%)	15 (79%)	4 (21%)	2 (50.0%)	2 (50.0%)
Sample receiving area	50 (25.1%)	36 (72%)	14 (28%)	3 (21.4%)	11 (78.6%)
Automation area	52 (26.1%)	36 (69.2%)	16 (30.8%)	3 (18.8%)	13 (81.2%)
Deal with COVID-19 specimen
Yes	120 (60.3%)	89 (74.2%)	31 (25.8%)	6 (29.4%)	25 (80.6%)
No	79 (39.7%)	59 (74.7%)	20 (25.3%)	6 (30.0%)	14 (70.0%)
Transportation
Private	61 (30.7%)	48 (78.6%)	13 (21.4%)	2 (8.3%)	11 (91.7%)
Public	138 (69.3%)	100 (72.5%)	38 (27.5%)	10 (27.0%)	28 (73.0%)
Had family COVID-19 contact
Yes	69 (34.6%)	50 (72.5%)	19 (27.5%)	3 (15.8%)	16 (84.2%)
No	130 (65.4%)	98 (75.4%)	32 (24.6%)	9 (28.1%)	23 (71.9%)